CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
CD93 is a highly glycosylated transmembrane protein expressed on monocytes, neutrophils, endothelial cells, and stem cells. Antibodies directed at CD93 modulate phagocytosis, and CD93-deficient mice are defective in the clearance of apoptotic cells from the inflamed peritoneum. In this study we observe that CD93, expressed on human monocytes and neutrophils, is susceptible to phorbol dibutyrate-induced protein ectodomain shedding in a time- and dose-dependent manner. The soluble fragment found in culture supernatant retains the N-terminal carbohydrate recognition domain and the epidermal growth factor repeats after ectodomain cleavage. Importantly, a soluble form of the CD93 ectodomain was detected in human plasma, demonstrating that shedding is a physiologically relevant process. Inhibition of metalloproteinases with 1,10-phenanthroline inhibited shedding, but shedding was independent of TNF-alpha-converting enzyme (a disintegrin and metalloproteinase 17). Phorbol dibutyrate-induced CD93 shedding on monocytes was accompanied by decreased surface expression, whereas neutrophils displayed an increase in surface expression, suggesting that CD93 shed from the neutrophil surface was rapidly replaced by CD93 from intracellular stores. Cross-linking CD93 on human monocytes with immobilized anti-CD93 mAbs triggered shedding, as demonstrated by a decrease in cell-associated, full-length CD93 concomitant with an increase in CD93 intracellular domain-containing cleavage products. In addition, the inflammatory mediators, TNF-alpha and LPS, stimulated ectodomain cleavage of CD93 from monocytes. These data demonstrate that CD93 is susceptible to ectodomain shedding, identify multiple stimuli that trigger shedding, and identify both a soluble form of CD93 in human plasma and intracellular domain containing cleavage products within cells that may contribute to the physiologic role of CD93.
Bohlson
Suzanne S
SS
Department of Molecular Biology and Biochemistry, Center for Immunology, University of California-Irvine, 2419 McGaugh Hall, Irvine, CA 92697, USA. abohlson@uci.edu
Silva
Richard
R
Fonseca
Maria I
MI
Tenner
Andrea J
AJ
D051722:ADAM Proteins; D000072198:ADAM17 Protein; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism*; D003432:Cross-Linking Reagents / Q000378:metabolism; D015536:Down-Regulation / Q000276:immunology; D006031:Glycosylation; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D019041:L-Selectin / Q000096:biosynthesis / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000097:blood* / Q000276:immunology / Q000378:metabolism*; D008666:Metalloendopeptidases / Q000502:physiology; D009000:Monocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D011951:Receptors, Complement / Q000096:biosynthesis / Q000097:blood* / Q000276:immunology / Q000378:metabolism*; D020449:Repetitive Sequences, Amino Acid; D012995:Solubility; D020298:U937 Cells; D015854:Up-Regulation / Q000276:immunology
D003432:Cross-Linking Reagents; D018836:Inflammation Mediators; D008562:Membrane Glycoproteins; D011951:Receptors, Complement; C032402:complement 1q receptor; D019041:L-Selectin; D015240:Phorbol 12,13-Dibutyrate; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000072198:ADAM17 Protein